RAB LPACK13 Makes the Switch to LED Even Easier

Shipping now, the LPACK13 is a high-performance LED Wallpack that has even higher efficiency and faster payback for those making the switch to LED.

2010-10-12

NORTHVALE, NJ, October 12, 2010 (Press-News.org) RAB announces a big upgrade to the LPACK product line, raising the bar of performance for Affordable Outdoor LED Lighting. Shipping now, the LPACK13 is a high-performance LED Wallpack that has even higher efficiency and faster payback for those making the switch to LED.

The LPACK13 replaces 150W Metal Halide Wallpacks and can be mounted at heights up to 20 feet. Compared to the LPACK10, the LPACK13 produces 94% more lumens and is 84% more efficient, which in turn provides a higher return on investment (ROI) and faster payback. RAB has also upgraded the driver, with additional surge protection up to 4000 volts and compatibility with input voltage from 120-240V and 277V.

The LPACK13 comes in Energy Star approved configurations (consult factory for ordering details). In addition to Energy Star, the LPACK13 is classified as IESNA full-cutoff, fully shielded and is IDA Dark Skies Approved. LEED Buildings can use the LPACK13 to achieve LEED Points for Light Pollution Reduction.

The 13 watt LPACK is available in bronze or white finish and is suitable for both commercial and residential applications to light entrances, pathways and facades and is UL Listed for Wet Locations as a downlight and Damp Locations as an uplight.

RAB dramatically shrunk the carbon footprint of the traditional wallpack with a unique design specifically engineered for LED technology, resulting in 50% less aluminum and glass. RAB Engineers use state of the art computational fluid dynamics software to assure LED Light Engine life is optimized for long term use.

LPACK13 is LM-79 and LM-80 tested, has earned the U.S. Department of Energy's Lighting Facts label and L70 Lifetime Determination data is available upon request. All RAB LED products carry a five-year warranty, which covers the fixture and the components.

The LPACK13 is a patent pending design and is protected under U.S. and international intellectual property laws. RAB Lighting offers a complete line of high-quality Commercial, Residential and Industrial Outdoor lighting, sold exclusively through electrical distributors. LPACK13 product images, e-learning modules and specifications are available at http://www.rabweb.com/LPACK13. For additional information, contact Bob Meade, Marketing Coordinator, RAB Lighting, 888 722-1000, bob@rabweb.com or visit www.rabweb.com.

RAB Lighting is one of the country's leading manufacturers of Outdoor Lighting Fixtures and Motion Sensor Controls. For more information, please contact us at (888) 722-1000.

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Dogs' anxiety reflects a 'pessimistic' mood

2010-10-11

Many dogs become distressed when left home alone, and they show it by barking, destroying things, or toileting indoors. Now, a new study reported in the October 12th issue of Current Biology, a Cell Press publication, suggests that this kind of separation anxiety occurs most often in dogs that also show "pessimistic"-like behavior. "We know that people's emotional states affect their judgments; happy people are more likely to judge an ambiguous situation positively," said Mike Mendl of the University of Bristol. "Now it seems that this may also apply to dogs; dogs that ...

Dogs may be pessimistic too

2010-10-11

A study has gained new insight into the minds of dogs, discovering that those that are anxious when left alone also tend to show 'pessimistic' like behaviour. The research by academics at the University of Bristol, and funded by the RSPCA is published in Current Biology tomorrow (12 October). The study provides an important insight into dogs' emotions, and enhances our understanding of why behavioural responses to separation occur. Professor Mike Mendl, Head of the Animal Welfare and Behaviour research group at Bristol University's School of Clinical Veterinary Science, ...

Intriguing viral link to intestinal cancer in mice

2010-10-11

More than 50% of adults in the United States test positive for human cytomegalovirus (HCMV) infection. For most people, infection produces no symptoms and results in the virus persisting in the body for a long time. HCMV infects many cell types in the body including the cells that line the intestines (IECs). New research, led by Sergio Lira, at Mount Sinai School of Medicine, New York, shows that mice engineered to express the HCMV protein US28 in IECs develop intestinal tumors as they age. These mice also develop more tumors than normal mice in a model of inflammation-induced ...

JCI online early table of contents: Oct. 11, 2010

2010-10-11

EDITOR'S PICK: Intriguing viral link to intestinal cancer in mice More than 50% of adults in the United States test positive for human cytomegalovirus (HCMV) infection. For most people, infection produces no symptoms and results in the virus persisting in the body for a long time. HCMV infects many cell types in the body including the cells that line the intestines (IECs). New research, led by Sergio Lira, at Mount Sinai School of Medicine, New York, shows that mice engineered to express the HCMV protein US28 in IECs develop intestinal tumors as they age. These mice ...

UF research provides new understanding of bizarre extinct mammal

2010-10-11

GAINESVILLE, Fla. --- University of Florida researchers presenting new fossil evidence of an exceptionally well-preserved 55-million-year-old North American mammal have found it shares a common ancestor with rodents and primates, including humans. The study, scheduled to appear in the Oct. 11 online edition of the Zoological Journal of the Linnean Society, describes the cranial anatomy of the extinct mammal, Labidolemur kayi. High resolution CT scans of the specimens allowed researchers to study minute details in the skull, including bone structures smaller than one-tenth ...

Swimming microorganisms stir things up, and the LHC takes over

2010-10-11

Two separate research groups are reporting groundbreaking measurements of the fluid flow that surrounds freely swimming microorganisms. Experiments involving two common types of microbes reveal the ways that one creature's motion can affect its neighbors, which in turn can lead to collective motions of microorganism swarms. In addition, the research is helping to clarify how the motions of microscopic swimmers produces large scale stirring that distributes nutrients, oxygen and chemicals in lakes and oceans. A pair of papers describing the experiments will appear in the ...

Novocure reports data showing TTF therapy in combination with chemotherapy has the potential to increase overall survival for patients with advanced non-small cell lung cancer

2010-10-11

### ABOUT NOVOCURE Novocure is a subsidiary of Jersey Isle based Standen Ltd., an oncology company pioneering tumor treating fields (TTF) therapy, a new modality for treating solid tumors. Novocure’s US operations are based in Portsmouth, NH and the company’s research center is located in Haifa, Israel. For additional information about Novocure, please visit www.novocuretrial.com. EDITORS NOTE: High resolution device photos available by request. 1Nasser Hanna et al; "Randomized Phase III Trial of Pemetrexed versus Docetaxel in Patients with Non-Small-Cell Lung Cancer ...

Research discovers how the deaf have super vision

2010-10-11

Deaf or blind people often report enhanced abilities in their remaining senses, but up until now, no one has explained how and why that could be. Researchers at The University of Western Ontario, led by Stephen Lomber of The Centre for Brain and Mind have discovered there is a causal link between enhanced visual abilities and reorganization of the part of the brain that usually handles auditory input in congenitally deaf cats. The findings, published online in Nature Neuroscience, provide insight into the plasticity that may occur in the brains of deaf people. Cats ...

Scripps Research study challenges conventional theory of modern drug design

2010-10-11

JUPITER, Fl, October 7, 2010 – Scientists from The Scripps Research Institute have uncovered new evidence that challenges the current theory about a process key to the way modern drugs are designed and how they work in the human body. The new study was published October 10, 2010 in an advance, online edition of the journal Nature Chemical Biology. Currently, the theory about ligands – compounds that bind to proteins and trigger a specific biological action – and how they bind to proteins runs along the lines of a one person-one vote paradigm. Ligands are considered ...

Gladstone scientists link hepatitis C virus infection to fat enzyme in liver cells

2010-10-11

SAN FRANCISCO, CA—October 10, 2010—Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have found that an enzyme associated with the storage of fat in the liver is required for the infectious activity of the hepatitis C virus (HCV). This discovery may offer a new strategy for treating the infection. More than 160 million people are infected throughout the world, and no vaccine is available to prevent further spread of the disease. Current treatments are not effective against the most common strains in the US and Europe. The study, published in the ...

LAST 30 PRESS RELEASES:

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury